rs563345694
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2
The NM_001127222.2(CACNA1A):c.6125C>T(p.Thr2042Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000639 in 1,610,832 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T2042T) has been classified as Benign.
Frequency
Consequence
NM_001127222.2 missense
Scores
Clinical Significance
Conservation
Publications
- episodic ataxia type 2Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
- developmental and epileptic encephalopathy, 42Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- migraine, familial hemiplegic, 1Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- spinocerebellar ataxia type 6Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
- benign paroxysmal torticollis of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial or sporadic hemiplegic migraineInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lennox-Gastaut syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1A | ENST00000360228.11 | c.6125C>T | p.Thr2042Met | missense_variant | Exon 42 of 47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
| CACNA1A | ENST00000638029.1 | c.6143C>T | p.Thr2048Met | missense_variant | Exon 43 of 48 | 5 | ENSP00000489829.1 | |||
| CACNA1A | ENST00000573710.7 | c.6131C>T | p.Thr2044Met | missense_variant | Exon 42 of 47 | 5 | ENSP00000460092.3 | |||
| CACNA1A | ENST00000635727.1 | c.6128C>T | p.Thr2043Met | missense_variant | Exon 42 of 47 | 5 | ENSP00000490001.1 | |||
| CACNA1A | ENST00000637769.1 | c.6128C>T | p.Thr2043Met | missense_variant | Exon 42 of 47 | 1 | ENSP00000489778.1 | |||
| CACNA1A | ENST00000636012.1 | c.6128C>T | p.Thr2043Met | missense_variant | Exon 42 of 46 | 5 | ENSP00000490223.1 | |||
| CACNA1A | ENST00000637736.1 | c.5987C>T | p.Thr1996Met | missense_variant | Exon 41 of 46 | 5 | ENSP00000489861.1 | |||
| CACNA1A | ENST00000636389.1 | c.6128C>T | p.Thr2043Met | missense_variant | Exon 42 of 47 | 5 | ENSP00000489992.1 | |||
| CACNA1A | ENST00000637432.1 | c.6143C>T | p.Thr2048Met | missense_variant | Exon 43 of 48 | 5 | ENSP00000490617.1 | |||
| CACNA1A | ENST00000636549.1 | c.6134C>T | p.Thr2045Met | missense_variant | Exon 43 of 48 | 5 | ENSP00000490578.1 | |||
| CACNA1A | ENST00000637927.1 | c.6131C>T | p.Thr2044Met | missense_variant | Exon 42 of 47 | 5 | ENSP00000489715.1 | |||
| CACNA1A | ENST00000635895.1 | c.6128C>T | p.Thr2043Met | missense_variant | Exon 42 of 47 | 5 | ENSP00000490323.1 | |||
| CACNA1A | ENST00000638009.2 | c.6128C>T | p.Thr2043Met | missense_variant | Exon 42 of 47 | 1 | ENSP00000489913.1 | |||
| CACNA1A | ENST00000637276.1 | c.6128C>T | p.Thr2043Met | missense_variant | Exon 42 of 46 | 5 | ENSP00000489777.1 | |||
| CACNA1A | ENST00000636768.2 | n.*427C>T | non_coding_transcript_exon_variant | Exon 41 of 45 | 5 | ENSP00000490190.2 | ||||
| CACNA1A | ENST00000713789.1 | n.*1340C>T | non_coding_transcript_exon_variant | Exon 43 of 47 | ENSP00000519091.1 | |||||
| CACNA1A | ENST00000636768.2 | n.*427C>T | 3_prime_UTR_variant | Exon 41 of 45 | 5 | ENSP00000490190.2 | ||||
| CACNA1A | ENST00000713789.1 | n.*1340C>T | 3_prime_UTR_variant | Exon 43 of 47 | ENSP00000519091.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152144Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000374 AC: 9AN: 240506 AF XY: 0.0000460 show subpopulations
GnomAD4 exome AF: 0.0000651 AC: 95AN: 1458688Hom.: 0 Cov.: 34 AF XY: 0.0000607 AC XY: 44AN XY: 725350 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74308 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
- -
In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 30755392) -
- -
- -
CACNA1A-related disorder Uncertain:1
The CACNA1A c.6125C>T variant is predicted to result in the amino acid substitution p.Thr2042Met. This variant was reported in an individual with cerebral white matter abnormalities, cerebral venous thrombosis, myelitis, immunodeficiency, and spasticity (referred to as c.6128C>T, p.Thr2043Met in Supplemental Table 2, Ji et al. 2019. PubMed ID: 30755392). This variant is reported in 0.0058% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-13323262-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Spinocerebellar ataxia type 6;C1720416:Episodic ataxia type 2;C1832884:Migraine, familial hemiplegic, 1;C4310716:Developmental and epileptic encephalopathy, 42 Uncertain:1
- -
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at